The Explosive History of Hydrogen – With Andrew Szydlo
Andrew Szydlo takes us on a whistle-stop tour of this reactive gas, originally called "flammable air", recreating some long-lost experiments along the way.
Key Techniques in Structural Biology, Their Strengths and Limitations
Structural biology uses a variety of techniques to determine the 3D structures of biomolecules such as proteins, nucleic acids and their complexes. In this article, we consider the key techniques, their role in structural biology, strengths and limitations.
Drug With Potential To Ease Pain in Osteoarthritis Moves to Clinical Trial
Results from an animal study published in Science Translational Medicine demonstrate that a drug compound can disrupt overactivation of inflammation and manage pain and stiffness in osteoarthritis. The drug will be tested in upcoming Phase I and IIa clinical trials.
AI Predicts Genetics of Brain Cancers in Less Than 90 Seconds
Researchers hope the AI tool will improve diagnosis and treatment of cancerous brain tumors, as well as boost clinical trial enrollment.
Brain Prize 2023 Awarded for Pioneering Synaptic Plasticity Research
The Lundbeck Foundation has announced the recipients of The Brain Prize 2023, the world’s largest award for outstanding contributions to neuroscience.
Fragment-Based Drug Discovery Enters the Mainstream
This article will discuss the principles of fragment-based drug discovery and will highlight some examples of recent successes in this area.
The Pulse: Psychedelic News From Technology Networks Issue 2
Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.
Passage of the FDA Modernization Act Enables New Era for Preclinical Testing
The 11th-hour passage of The FDA Modernization Act gave a much-needed boost to the advocates of new alternative methods (NAMs) for preclinical testing. In this article, we take a look at why NAMs are needed and what the new legislation means for pharmaceutical companies.
Time To Say Goodbye to the Traditional BMI?
Scientists from the Institute for Systems Biology (ISB) have created a biological BMI, an alternative to the "traditional" approach. Technology Networks interviewed the lead researchers to understand why it could be a useful alternative measure of health.
How To Guide
How To Future-Proof Your LIMS: Handling Software Updates
Download this guide to explore types of LIMS upgrades, on-premises installation and SaaS installation.
How To Guide
CRISPR Yeast: Replacing the Need for Plant-Derived Metabolites
Plant-derived compounds are widely used across the pharmaceutical, cosmetics, food and agricultural industries. However, compared to other natural compounds, they often produce a lower yield of secondary metabolites.
High-Throughput Screening in Drug Discovery
Download this listicle to learn more about high-throughput screening, biochemical assays and cell-based assays.
Chemical Analysis in the Petrochemicals Sector
Download this listicle to discover the need for petrochemical analysis and how safety and quality standards are maintained using different analysis techniques.